drugset / Trial / NCT00275418

Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease

NCT00275418

Phase 3 Unknown 300 enrolled Bnai Zion Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

Many inflammatory disorders in the body are linked to oxidative tissue damage. Anti-oxidants that are present in many natural food sources may provide protection from such damage. Beta carotene is an anti-oxidant vitamin present in many fruits and vegetables. The algae Dunaliella is particularly rich in beta carotene. In this prospective trial we want to investigate whether beta carotene from Dunaliella may prevent exacerbations of Crohn's disease.

Timeline

Start
2002-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject beta-carotene Small molecule 60 mg

Indications